INTRODUCTION
============

The multiport laparoscopic approach for sigmoid resection has been shown to ameliorate patient recovery.^[@B1][@B2][@B3]^ More recently, Gervaz et al reported a 30% reduction in the duration of postoperative ileus and hospital stay when comparing laparoscopic versus open resection.^[@B4]^ Single-incision laparoscopic surgery (SILS) has developed over recent years and is gaining popularity in several surgical specialties including colorectal surgery.^[@B5]^ The theoretical benefits of SILS include less pain, earlier discharge, and a better cosmetic result. However, technical challenges in SILS include a lack of triangulation and limited space to manipulate the surgical instruments. Well-designed studies comparing conventional multiport laparoscopic sigmoidectomy (MLS) with SILS sigmoidectomy (SILSS) are limited. In this single-institution study, we aimed to examine the safety, feasibility, and outcomes of SILSS for recurrent diverticulitis compared with a cohort undergoing MLS in the same time period.

PATIENTS AND METHODS
====================

Patients
--------

The indications for surgery were established according to the guidelines of the American Society of Colon and Rectal Surgeons.^[@B6]^ All patients underwent elective MLS or SILSS with primary anastomosis. Surgery was performed a minimum of 6 weeks after the patient\'s last episode of acute diverticulitis. After institutional review board approval, we retrospectively reviewed the charts of all patients who underwent a SILSS or MLS procedure for recurrent diverticulitis performed between October 2011 and February 2013 at our institution.

For each patient, the following variables were collected from our prospectively maintained database: age, gender, body mass index, previous abdominal surgery, number of episodes of acute diverticulitis, Hinchy classification of the most severe episode, Hinchy classification of the most recent episode, duration of operation, amount of blood loss, conversion to open surgery or addition of extra trocars, and postoperative data including morbidity, mortality, duration of epidural anesthesia, use of intravenous analgesics, and length of hospital stay. The Clavien-Dindo classification system, validated and tested for interobserver variation, was used to classify the severity and nature of complications.^[@B7],[@B8]^ Furthermore, overall satisfaction and evaluation of the cosmetic result were evaluated on a scale ranging from 0 (very unhappy) to 10 (completely satisfied). These scores were previously used in a recent published randomized trial comparing open versus laparoscopic sigmoid resection for diverticulitis.^[@B9]^

Finally, a cost analysis was performed comparing the total cost of the disposable surgical items (linear staplers, energy devices, circular staplers, trocars or single-incision access platform) in both groups.

Anesthesia Protocol
-------------------

Our protocol for general anesthesia consists of a balanced anesthesia using volatile anesthetics such as sevoflurane in association with a continuous infusion of remifentanil, a potent ultrashort-acting synthetic opioid analgesic.^[@B10]^ Before patient induction, an epidural catheter was inserted into the 10--11 thoracal epidural space. After preoxygenation (6 L/min for 5 min through a face mask), anesthesia was induced using an intravenous bolus of propofol, a hypnotic agent, until the patient lost consciousness. A continuous infusion of remifentanil was started 2 minutes before induction at 0.25 g/kg/min based on the patient\'s ideal body weight. After complete induction, a 0.5-mg/kg intravenous bolus of atracurium, a nondepolarizing neuromuscular blocker, was administered. Two minutes after atracurium administration, the patient was intubated and top-up doses of atracurium were given every 20 minutes. The dose of remifentanil, initiated at 0.25 μg/kg/min, was adjusted up or down according to the patient\'s hemodynamic responses. Each patient received either sevoflurane or desflurane in an air-oxygen admixture. The protocol was based on the measurement of end-tidal anesthetic gas concentrations. Oxygen saturation was maintained 95% and end-tidal carbon dioxide was maintained between 35 and 45 mm Hg, with ventilatory settings left to the discretion of the anesthesiologist. The positive end-expiratory pressure was set at 5 cm H~2~O. After intubation, patients received 1 g of intravenous (IV) paracetamol and IV ibuprofen 75 mg if they were not contraindicated.

Surgical Technique
------------------

Preoperatively, we administered a phosphate-based enema. Patients were given standard IV prophylactic antibiotics to treat gram-negative and anaerobic bacteria. A urinary catheter and compression lower-leg boots were placed. The patient was placed in the lithotomy position with moderate Trendelenburg and right-sided tilt. The rectum was irrigated with povidone-iodine.

SILS Sigmoidectomy
------------------

A pneumoperitoneum was created with a Veress needle in the umbilicus. A 3-cm incision was made through the umbilicus. The Gelpoint access platform (Applied Medical, Rancho Santa Margarita, California) was used in all cases. The pneumoperitoneum was maintained at 15 mm Hg. No curved or articulating instruments were used. The left and sigmoid colon were mobilized using the medial to lateral approach. The left gonadal vessels and the ureter were identified. The inferior mesenteric artery and vein were transected with a 45-mm EndoGIA white stapler (Covidien, EndoGIA Universal roticulator 45--2-0, Norwalk, Connecticut). The hypogastric plexus nerves were preserved. The lateral attachments (line of Toldt) were released. The mesorectum was dissected from the bowel at the level of the proximal rectum to prepare the distal margin of resection using the LigaSure dolphin tip (Covidien, Boulder, Colorado). The high rectum was transected with a linear cutting roticulating stapler (EndoGIA, 60 mm purple cartridge, Covidien). The sigmoid colon was recovered through the umbilical wound protector that is part of the Applied Gelpoint access platform. The sigmoid was resected and the anvil of a 28-mm circular stapler (DST series PCEEA; Covidien) was inserted in the descending colon and secured with a 2--0 Prolene purse-string suture (Ethicon, Norderstedt, Germany). The bowel was returned to the peritoneal cavity and the pneumoperitoneum was re-established. The procedure was completed by joining the anvil to the circular stapler passed transanally, creating an end-to-end double-stapled anastomosis. Once completed, the anastomosis was tested under a water bath for evidence of leakage. No drains were left. At the end of the procedure, the wound protector was removed and the wound was closed in layers.

Conventional Multiport Laparoscopic Sigmoidectomy
-------------------------------------------------

Most of the steps in performing the MLS are the same as those described for the SILSS.

A pneumoperitoneum was created with a Veress needle in the left hypochondrium. Four ports were used; a 5-mm port was placed just to the right of the umbilicus for the 30-degree 5-mm camera and 3 additional trocars were placed as follows: a 12-mm trocar just medial and superior to the anterior superior iliac spine, a 5-mm trocar in the left iliac fossa, and a 5-mm trocar in the right flank lateral to the epigastric vessels. The pneumoperitoneum was maintained at 15 mm Hg. A medial to lateral approach was used for submesocolic dissection as in the SILSS group. The mesorectum was dissected from the bowel at the level of the proximal rectum to prepare the distal margin of resection using the Harmonic ACE dissector (Ethicon EndoSurgery GmbH, Norderstedt, Germany). The same stapling devices were used in the SILSS group. For extracting the sigmoid colon, a 5-cm incision was made at the position of the left trocar in the left iliac fossa and a wound protector (ALEXIS Wound Retractor, small; Applied Medical, Rancho Santa Margarita, California) was inserted. At the end of the procedure, the wound protector was removed and the incision was closed in layers.

Postoperative Care
------------------

Although we have not implemented an enhanced recovery after surgery program for colectomy at our institution, postoperative management of these patients includes avoidance of using nasogastric tubes, early dietary advancement, and early ambulation.

For postoperative pain management, all patients received a patient-controlled analgesia device (GemStarTM Infusion System, Hispira, Inc, Lake Forest, Illinois). A patient-controlled epidural analgesia device was preferred. A loading dose was administered at the end of the surgical procedure; pain therapy using IV paracetamol and IV ibuprofen had already been undertaken during anesthesia and was continued afterward. Intravenous paracetamol 1 g was administered every 6 hours; IV ibuprofen 75 mg was given only on demand. Postoperative pain control was assessed using a 10-cm visual analog scale (VAS) (0 = no pain, 10 = worst pain) and recorded in the patient\'s file by nurses.

Regular laboratory tests were performed on postoperative days 1, 3, and 5. Average time to flatus and bowel movement was recorded.

Data Collection and Statistical Analysis
----------------------------------------

Data were retrieved from routine prospective electronic and paper patient files. For all statistical analyses, SAS version 9.1.3 (SAS Institute, Cary, North Carolina) was used. Analysis was performed using the Fisher exact test (discrete variables), the Student *t* test or the Wilcoxon rank-sum test (continuous variables) depending on normality (or non-normality) of variables. The Mantel-Haenszel χ^2^ test was used as appropriate to test differences between the groups. Statistical significance was set at an alpha of .05 for all analyses.

RESULTS
=======

Demographics---Clinicopathological Characteristics
--------------------------------------------------

Patient and clinicopathological characteristics are summarized in **[Table 1](#T1){ref-type="table"}**. Age, gender, American Society of Anesthesiologists (ASA) score, and body mass index were comparable between the 2 groups. Furthermore, the percentage of patients who had undergone previous abdominal surgery, the number of episodes of acute diverticulitis, the severity of attacks, and the severity of the most recent attack of diverticulitis were also comparable between the 2 groups.

###### 

Clinicopathologic Characteristics of Patients Undergoing Sigmoidectomy for Diverticulitis

  Variable                              Overall (n = 60)   SILSS Group (n = 20)   MLS Group (n = 40)   *P* value
  ------------------------------------- ------------------ ---------------------- -------------------- -----------
  Age, y (range)                        61 (39--78)        60 (39--77)            61 (44--78)          .7866
  Sex (F/M)                             23/37              7/13                   16/24                .7833
  ASA score                                                                                            1.000
      1                                 30                 9                      21                   
      2                                 20                 10                     11                   
      3                                 9                  1                      8                    
      4                                 0                  0                      0                    
  BMI, kg/m^2^ (range)                  24.5 (19--36)      25 (21--31)            24 (19--36)          .8993
  Previous abdominal surgery            20                 6                      14                   .7775
  No. episodes diverticulitis (range)   3 (2--5)           3 (2--5)               3 (2--6)             .8860
  Most severe episode (Hinchy I/II))    41/19              14/6                   27/13                1.000
  Last episode (Hinchy I/II)            47/13              16/4                   31/9                 1.000

Surgical and Postoperative Outcomes
-----------------------------------

Surgical outcomes of SILSS versus MLS are shown in **[Table 2](#T2){ref-type="table"}**. The mean operative time for SILSS was 13 minutes longer than it was for MLS (*P* = .0012). Estimated blood loss was similar and minimal in both groups. In a larger proportion of patients in the SILSS group, 2 linear staplers were needed for transection at the rectum compared with the MLS group (11/20 \[55%\] vs 7/40 \[17.5%\]). However, this did not result in a higher anastomotic leak rate. There was one conversion to open surgery in the MLS group. In 2 patients in the MLS group, an additional 5-mm port was required. No additional ports were needed in patients in the SILSS group.

###### 

Surgical Outcomes

  Variable                                                   Overall (n = 60)   SILSS Group (n = 20)   MLS Group (n = 40)   *P* value
  ---------------------------------------------------------- ------------------ ---------------------- -------------------- -----------
  Operating time (± SD)                                      95.2 (±15.3)       104 (±12.1)            90.9 (±14.9)         **.0012**
  Blood loss (mL) (± SD)                                     14.2 (±24.5)       15 (±23.5)             13.7 (25.3)          .9414
  Preoperative complication                                  0                  0                      0                    1.000
  Conversion to open                                         1                  0                      1                    1.000
  Additional ports placement                                 2                  0                      2                    .548
  Number of linear staplers (1/2)                            (42/18)            (9/11)                 (33/7)               **.006**
  Length of specimen[\*](#TF2-1){ref-type="table-fn"} (cm)   18 (15--24)        19 (15--24)            18 (16--24)          .1629

After fixation.

The specimen length was similar in both groups (*P* = .1629). All postoperative outcomes are summarized in **[Table 3](#T3){ref-type="table"}**. All patients received patient-controlled epidural analgesia. The rate of postoperative complications was not significantly different between the 2 groups. In all, 22 (36.7%) patients had a Clavien-grade complication; all complications were Clavien grade I or II. One anastomotic leak occurred in the MLS group. This patient had a 25-mm large intraabdominal abscess along with a small anastomotic defect at the stapler line, which was confirmed by a computed tomography scan. The patient was readmitted because of fever 10 days after surgery and was treated conservatively with IV antibiotics (meropenem 3 × 2 g/d for 1 week). There were no deaths in either group. Postoperative recovery with respect to return to bowel function or return to oral intake was faster in the SILSS group than in the MLS group (*P* = .0446 and *P* = .0137, respectively). Although duration of epidural anesthesia was equal in both groups and there was no difference in nonsteroidal antiinflammatory drug (NSAID) use, a significant reduction in pain was noted on days 1 and 2 postoperatively when comparing VAS scores. Length of hospital stay was shorter in the SILSS group but not statistically significant (*P* = .0536). There were 3 readmissions: one from the SILSS group because of gastroparesis with nausea and vomiting and two in the MLS because of, respectively, pneumonia and a pelvic abscess at the stapler line that was considered a small clinical anastomotic leakage. All patients were treated conservatively using IV antibiotics.

###### 

Postoperative Outcomes

  Variable                                                         Overall (n = 60)   SILSS Group (n = 20)   MPS Group (n = 40)   *P* value
  ---------------------------------------------------------------- ------------------ ---------------------- -------------------- -----------
  Postoperative complication                                       22                 7                      15                   1.000
      Clavien I                                                    6                  2                      4                    1.000
      Clavien II                                                   16                 5                      11                   1.000
      Clavien III                                                  0                  0                      0                    1.000
      Clavien IV                                                   0                  0                      0                    1.000
  Bowel function (movement/gas)[\*](#TF3-1){ref-type="table-fn"}   2 (1--8)           2 (1--2)               2 (1--8)             **.0446**
  Oral intake[\*](#TF3-1){ref-type="table-fn"}                     1 (1--6)           1 (1--2)               1.5 (1--6)           **.0137**
  Epidural out[\*](#TF3-1){ref-type="table-fn"}                    3 (1--4)           2 (2--4)               3 (1--4)             .1673
  Need for NSAID                                                   24                 7                      17                   .7804
  Pain scores                                                                                                                     
      Max pain score day 1 (1--10)                                 2.77 (0.65)        2.40 (0.50)            2.95 (0.64)          **.0014**
      Max pain score day 2 (1--10)                                 2.08 (0.46)        1.85 (0.49)            2.2 (0.41)           **.0047**
      Max pain score day 3 (1--10)                                 1.40 (0.53)        1.55 (0.60)            1.6 (0.50)           .7337
  Discharge[\*](#TF3-1){ref-type="table-fn"}                       6.03 (±1.78)       5.5 (±1.15)            6.3 (±1.99)          .0536
  Readmission rate                                                 3                  1                      2                    1.000

Days postoperatively.

Cost Analysis and Long-Term Outcomes
------------------------------------

The cosmetic result was better in the SILSS group. Results for overall satisfaction reached borderline statistical significance and hospital stay was also borderline statistically shorter when compared with MLS (**[Table 4](#T4){ref-type="table"}**). The average total cost of the disposable surgical items was higher in the SILSS group (€2599) than in the MLS group (€2320) (*P* \< .0001). The hernia rate was low and similar in both groups.

###### 

Cost Analysis and Long-Term Outcomes

  Variable                                           Overall (n = 60)    SILSS Group (n = 20)   MPS Group (n = 40)   *P* value
  -------------------------------------------------- ------------------- ---------------------- -------------------- --------------
  Cost disposable[\*](#TF4-1){ref-type="table-fn"}   2413.09 (±178.19)   2599.02 (±127.28)      2320.13 (±116.40)    **\< .0001**
  Cosmetic result                                    7.98 (±1.33)        8.75 (±1.07)           7.60 (±1.30)         **.0011**
  Overall satisfaction                               8.18 (±1.89)        8.5 (±0.89)            8.02 (± 0.86)        .0511
  Hernia rate                                        3                   1                      2                    1.000

In Euros (€).

DISCUSSION
==========

As is shown in **[Table 5](#T5){ref-type="table"}**, several case series of SILS colectomy have been published recently. However, few comparative studies have been published comparing single-incision laparoscopic colectomy with standard laparoscopic multiport colectomy. As stated in a recent systematic review, there is significant heterogeneity in study group characteristics, indications for surgery and operative techniques.^[@B30]^ Most reports are case series that include benign (ie, diverticulitis, endometriosis, colitis, polyps not amendable to colonoscopic polypectomy) and malignant conditions and include different types of resections (ie, right, transverse, total and left colectomies). In our comparative study, we only included one specific type of benign colonic disease. All patients underwent the same type of colonic resection by the same surgeon, which reduces the heterogeneity of this study. We currently do not perform SILS colectomies for malignant conditions. Questions remain about the safety of SILS for colorectal cancer resection and there are no data on its long-term outcomes (disease-free or disease-specific survival).^[@B31]^

###### 

Overview of Published SILS Colectomy Series Including [\>]{.ul}20 Patients

  Series                               Case Series Comparative   No. Cases   Benign/Malignancy/Mixed   Right-Sided/Left-Sided/Mixed
  ------------------------------------ ------------------------- ----------- ------------------------- ------------------------------
  Champagne et al^[@B11]^              Comparative               147         Mixed                     Mixed
  Geisler and Garrett^[@B12]^          Case series               63          Mixed                     Mixed
  Ramos-Valadez et al^[@B13]^          Comparative               20          Mixed                     Left
  Gajoux et al^[@B14]^                 Comparative               22          Benign                    Mixed
  Chew et al^[@B15]^                   Case series               28          Mixed                     Mixed
  Champagne et al^[@B16]^              Comparative               29          Mixed                     Mixed
  McNally et al^[@B17]^                Comparative               27          Malignancy                Mixed
  Katsuno et al^[@B18]^                Case series               31          Malignancy                Mixed
  Papaconstantinou et al^[@B19]^       Comparative               29          Mixed                     Right
  Lee et al^[@B20]^                    Comparative               42          Mixed                     Mixed
  Van den Boezem and Sietses^[@B21]^   Case series               50          Mixed                     Mixed
  Ross et al^[@B22]^                   Case series               38          Mixed                     Mixed
  Boni et al^[@B23]^                   Case series               36          Mixed                     Right
  Ramoz-Valadez et al^[@B24]^          Case series               35          Mixed                     Mixed
  Kwag et al^[@B25]^                   Comparative               24          Malignancy                Left
  Lu et al^[@B26]^                     Comparative               27          Malignancy                Mixed
  Fujii et al^[@B27]^                  Comparative               23          Malignancy                Mixed
  Vestweber et al^[@B28]^              Case series               224         Mixed                     Mixed
  Keshava et al^[@B29]^                Case series               22          Mixed                     Right
  Current series                       Comparative               20          Benign                    Left

Most published series are either not comparative or include different types of resections or different types of colonic disease, creating significant heterogeneity.

The SILSS and MLS groups were comparable for age, gender and ASA distribution and body mass index. There was no significant difference between the 2 groups in terms of history of previous abdominal surgery, number and severity of episodes of diverticulitis and severity of the last episode of diverticulitis. These factors could potentially influence the operative difficulty and subsequently the complication rate and further outcome.

Several aspects of SILSS differ from the MLS procedure, including the camera view, crossing hands during dissection, and lack of triangulation. This is reflected in a longer average operative time for SILSS in our study. Operative time was 104 minutes for the SILSS procedure, which is only 13.1 minutes longer than the 90.9 minutes required for the MLS. However, this difference was statistically different. Estimated blood loss was equivalent in both groups. Regarding conversion, a recently published German single-center experience with SILS colectomy reported a conversion rate to open surgery of 6.3%, half of which were in patients undergoing sigmoid colectomy with a high anterior resection or left hemicolectomy, 95% of whom had diverticulitis.^[@B28]^ In the current series, no cases were converted to open surgery and no additional ports were placed in the SILSS group. One case in the MLS group had to be converted to open surgery because of extensive adhesions. This 52-year-old female patient had a previous history of extensive surgery for endometriosis including hysterectomy and ovariectomy. The proportion of cases requiring 2 linear staplers to achieve full transection of the proximal rectum was higher in the SILSS group. This indicates a higher risk of oblique stapling in the SILS procedures. In the SILSS group, the linear stapler device was placed through the single-port device in the umbilicus, creating a difficult angle for complete tranverse rectal stapling because the axis of the stapler is in parallel with the axis of the rectum. Therefore an additional stapler was needed in more than half of single-port procedures. In the MLS group, the stapler was placed through the 12-mm port in the left lower quadrant, facilitating transverse stapling of the proximal rectum.

In another recent case-matched study, the same findings were published regarding the number of staplers.^[@B25]^ However, in their series the leakage rate was higher in the SILSS group. We did not find a higher leakage rate in the SILSS group compared with the MLS group or in the subset of cases in which 2 staplers were used.

In patients requiring 2 linear staplers, the area where the 2 stapler lines crossed was used for the circular stapled anastomosis. In this study, the Clavien-Dindo classification system, validated and tested for interobserver variation, was used to classify the severity and nature of complications.^[@B7],[@B8]^ The overall complication rate was 36.7% (35% in the SILSS group and 37.5% in the MLS group, *P* = 1.000). Not only the frequency but also the severity of complications was the same when the Clavien-Dindo classification was used to compare both groups. One clinical anastomotic leak was noted in the MLS group. Only one stapler was used to transect the rectum in this patient. The patient was readmitted because of fever and was treated conservatively with IV antibiotics, so this was graded as a Clavien II complication. There were no deaths in either group. Another theoretical benefit of SILS is that there is less postoperative pain. There have been 2 randomized controlled trials comparing SILS with laparoscopic cholecystectomy, and both showed better pain profiles in the SILS group.^[@B32],[@B33]^ Of all nonrandomized case-comparison studies comparing SILS and multiport or hand-assisted laparoscopic colonic resections, only 3 studies assessed postoperative pain. Papaconstaniou et al found a significant reduction in postoperative pain in patients undergoing SILS colonic resection when looking at VAS scores on postoperative days 1 and 2. By postoperative day 3, the difference in pain scores was no longer significant. Their series included different resections and multiport and hand-assisted laparoscopic resections, which makes it a heterogeneous patient population. In our standardized population containing only SILSS and MLS, we found identical results. Furthermore, there was no statistical difference in the length of epidural analgesic use in our series nor need for NSAID usage between both groups. In contrast to these results, Lu et al reported that patients in the SILS group experienced more pain on postoperative day 1, and Wolthuis et al found no difference in pain levels.^[@B26],[@B34]^ In these 2 last reports, several types of resections were included in both groups. Currently, health care providers and health care systems are under extreme pressure to provide treatment modalities that are cost effective without compromising patient care. Therefore a cost analysis of the SILS approach compared with the traditional MLS approach was performed to compare total cost of the disposables. Total cost for disposables was higher in the SILSS group (€2599) than in the MLS group (€2320) (*P* \< .0001). However, the cost of the shorter hospital stay should be taken into consideration because hospital stay was also borderline statistically shorter when compared with MLS.

Our study had certain limitations. First, although we matched the 2 groups for different variables and although the patient characteristics in the 2 groups were comparable, this was not a randomized study and thus may have been prone to certain bias. Second, we do acknowledge interobserver variability and bias affecting the results, because the patients were reviewed in the clinic by the surgeon who performed the surgical procedure. Furthermore, several findings may be the result of a type 1 error because there are only 20 patients included in the SILSS group. Finally, a better comparison group would probably have been an MLS group with a comparable size extraction site at the midline as opposed to a muscle-splitting incision.

CONCLUSION
==========

Our results show that SILSS for diverticulitis is safe and can be performed without increasing morbidity. It is associated with significantly better short-term benefits including earlier recovery of bowel function and a significant reduction in postoperative pain and better cosmesis. Results for overall satisfaction reached borderline statistical significance, and hospital stay was also borderline statistically shorter when compared with MLS. Further well-conducted comparative studies are needed to confirm our findings.
